Phase 1 AML/MDS Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

B-ALLAML/MDST-ALL+1 more

St. Jude Children's Research Hospital108 enrolled2 locationsNCT04318678

Recruiting

Phase 1

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

Acute Myeloid LeukemiaMyelodysplastic SyndromesAML/MDS

Montefiore Medical Center38 enrolled2 locationsNCT05986240